BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37649025)

  • 1. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study.
    Wu Z; Xie L; Guo D; Chen S; Liu X; Sun X; Wang J; Zhang Y; Liu L; Cui H; Zang D; Yang J
    Cardiovasc Diabetol; 2023 Aug; 22(1):230. PubMed ID: 37649025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study.
    Wu Z; Cheng C; Sun X; Wang J; Guo D; Chen S; Zhang Y; Liu X; Liu L; Zhang C; Yang J
    Cardiovasc Diabetol; 2023 May; 22(1):103. PubMed ID: 37131230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-glucose index in the prediction of major adverse cardiovascular events in patients with type 2 diabetes mellitus after coronary artery bypass surgery: A retrospective cohort study.
    Zhang H; Chong H; Li Z; Li K; Zhang B; Xue Y; Wang D
    Front Endocrinol (Lausanne); 2022; 13():1015747. PubMed ID: 36339437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.
    Wu Z; Liu L; Wang W; Cui H; Zhang Y; Xu J; Zhang W; Zheng T; Yang J
    Cardiovasc Diabetol; 2022 Jul; 21(1):142. PubMed ID: 35906587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of the triglyceride-glucose index and EuroSCORE II improves the prediction of long-term adverse outcomes in patients undergoing coronary artery bypass grafting.
    Wu Z; Guo D; Chen S; Sun X; Zhang Y; Liu X; Liu L; Lin Z; Yang J
    Diabetes Metab Res Rev; 2023 Nov; 39(8):e3710. PubMed ID: 37537868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes.
    Tai S; Fu L; Zhang N; Yang R; Zhou Y; Xing Z; Wang Y; Zhou S
    Cardiovasc Diabetol; 2022 Aug; 21(1):161. PubMed ID: 35999546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease.
    Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Gao Y; Zheng J
    Cardiovasc Diabetol; 2023 Oct; 22(1):292. PubMed ID: 37891651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
    Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
    Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
    Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
    Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
    Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high triglyceride-glucose index associated with adverse cardiovascular events in patients with type 2 diabetes mellitus and chronic total occlusion after percutaneous coronary intervention.
    Lin XL; Li QY; Zhao DH; Liu JH; Fan Q
    J Investig Med; 2023 Jun; 71(5):471-481. PubMed ID: 36727463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI.
    Qin Z; Xu S; Yuan R; Wang Z; Lu Y; Xu Y; Lv Y; Yu F; Bai J; Zhang H; Zhang L; Zhang J; Tang J
    Diabetes Metab Syndr Obes; 2022; 15():3015-3025. PubMed ID: 36196143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Triglyceride-Glucose Index and 2-Year Adverse Cardiovascular and Cerebrovascular Events in Patients with Type 2 Diabetes Mellitus Who Underwent Off-Pump Coronary Artery Bypass Grafting.
    Chen L; Ding XH; Fan KJ; Gao MX; Yu WY; Liu HL; Yu Y
    Diabetes Metab Syndr Obes; 2022; 15():439-450. PubMed ID: 35210794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic score for insulin resistance in the prediction of major adverse cardiovascular events in patients after coronary artery bypass surgery: a multicenter retrospective cohort study.
    Zhang S; Wu Z; Zhuang Y; Sun X; Wang J; Chen S; Guo D; Xu P; Zhang C; Yang J
    Diabetol Metab Syndr; 2023 Jul; 15(1):157. PubMed ID: 37461067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.